Operating profit/ loss (EBIT) of LEO Pharma from 2008-2018

The Danish pharmaceutical company LEO Pharma made operating losses in 2009 and 2012, by 876 and 179 million Danish kroner, respectively. Since 2013, the company have only made operating profits, and with a significant increase in 2018 when it reached around 1.6 billion Danish kroner.

Operating profit/ loss (EBIT) of LEO Pharma from 2008 to 2018

Operating profit/ loss in million DKK
--
--
--
--
--
--
--
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

February 2019

Region

Denmark

Survey time period

2008 to 2018

Supplementary notes

Leo Pharma is a Danish pharmaceutical company founded 1908. The company's key products are dermatological pharmaceuticals, but they do also produce pharmaceuticals for other areas.

Some figures have been taken from previous publications.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.